Latest Janssen Research & Development LLC Stories
- Note: This release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608, LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053, 5014, 5028, TPS5071, TPS5084, 10503,
NEW BRUNSWICK, N.J., May 7, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen
HORSHAM, Pa., March 30, 2015 /PRNewswire/ -- The U.S.
Results served as basis for regulatory filing with U.S.
National Xarelto attorneys at the Onder Law Firm comment on a new Xarelto lawsuit accusing the drugmaker of fraud and negligence for concealing Xarelto's dangers. St.
Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic
NEW YORK, Feb.
Unique Approach Aims to Intercept Disease Prior to Onset and Preserve Health of People At-risk of Developing Type 1 Diabetes RARITAN, N.J., Feb.
New Focus in Disease Prevention, Disease Interception, and the Microbiome to Propel Scientific Innovation RARITAN, N.J., Feb.
RARITAN, N.J., Feb. 3, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
- A young chicken: also used as a pet name for children.